For the Inventor, By the Inventor

Enter inventor name

Menlo Park, CA, United States of America

Dennis M Brown

USPTO Granted Patents = 29 (Patent Applications = 29)

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 494(Granted Patents)

Location History:

San Mateo, CA (US) (1999)
Menlo Park, CA (US) (1986 - 2023)

Company Filing History:

Delmar Pharmaceuticals, Inc.

Del Mar Pharmaceuticals (bc) Ltd.

Matrix Pharmaceutical, Inc.

Chemgenex Pharmaceuticals, Inc.

Matrix Pharmaceuticals, Inc.

Chemgenex Therapeutics, Inc.

Matrix Pharmaceutical, Inc./project Hear

Valent Technologies LLC

10. 2 out of 832,843

Other

patents

Years Active: 1986-2025

Loading Chart...

Loading Chart...

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12336993 - Therapeutic benefit of suboptimally administered chemical compounds (2025-06-24),

2. 11717505 - Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas (2023-08-08),

3. 11541027 - Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases (2023-01-03),

4. 11491154 - Therapeutic benefit of suboptimally administered chemical compounds (2022-11-08),

5. 11446274 - Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies (2022-09-20),

6. 11234955 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma (2022-02-01),

7. 11026914 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor (2021-06-08),

8. 10383847 - Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo (2019-08-20),

9. 10201521 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma (2019-02-12),

10. 10138264 - Recombined molecules and preparation thereof (2018-11-27),

11. 9901563 - Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol (2018-02-27),

12. 9814693 - Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies (2017-11-14),

13. 9687466 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme (2017-06-27),

14. 9630938 - Method of synthesis of substituted hexitols such as dianhydrogalactitol (2017-04-25),

15. 9085544 - Method of synthesis of substituted hexitols such as dianhydrogalactitol (2015-07-21),

Title: The Innovative Journey of Dennis M Brown

Introduction: Dennis M Brown, a visionary inventor based in Menlo Park, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Dennis M Brown holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Dennis M Brown has worked for leading companies such as Tesla and Google X, where he played a key role in developing cutting-edge technologies.

Collaborations: Throughout his career, Dennis M Brown has collaborated with top researchers and engineers from renowned universities such as Stanford and MIT, fostering a culture of innovation and excellence.

Conclusion: Dennis M Brown's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and engineers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…